http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013133938-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 |
| filingDate | 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013133938-A |
| titleOfInvention | PHARMACOLOGICAL COMPOSITION FOR TREATMENT OF PROCTOLOGICAL DISEASES, AND ALSO VARIOUS MANIFESTATIONS OF VARICOSE EXPANSION OF VEINS (OPTIONS) |
| abstract | 1. Pharmacological composition, characterized in that it contains 1-20 wt.% Regenerant of methyluracil, 0.05-2 wt.% Calcium channel blocker is a calcium antagonist, 0.05-2 wt.% Donor of nitric oxide, 0.1- 4 wt.% Local anesthetic, pharmacologically acceptable carrier - the rest. 2. The pharmacological composition according to claim 1, characterized in that amlodipine, anipamil, aranidipine, azelnidipine, barnidipine, benidipine, bepridil, darodipine, dildiazem, silnidipine, clevidipine, lidipidin, lidipin, lidofin, lidinum, is used as a calcium channel blocker. , manidipine, mepirodipine, nicardipine, nifedipine, niludipine, nilvadipine, nimodipine, nisoldipine, nitrendipine, perhexiline, tipamil, verapamil, pranidipine, their salts, solvates, hydrates, as well as a mixture of any of them. 3. The pharmacological composition according to claim 1, characterized in that isopropyl nitrate, glyceryl-1-mononitrate, glyceryl-1,2-dinitrate, glyceryl-1,2-dinitrate, trinitroglycerin, butane-1,2, are used as a nitric oxide donor. 4-triol trinitrate, erythrityl tetranitrate, pentaerythritol tetranitrate, isosorbide mononitrate, isosorbide-2-mononitrate, isosorbide-5-mononitrate, isosorbide dinitrate or a mixture of these compounds. 4. The pharmacological composition according to claim 1, characterized in that proximetacaine, bupivacaine, benzocaine, bromanilidethiethylaminopropanoic acid, articaine, oxybuprocaine, lidocaine, tetracaine, diclonin, dimethylamino-benzoicaine, m-ricin, n-butylamino benzoic acid, a mixture of these compounds. 5. Pharmacological composition, characterized in that it consists of 5 wt.% Met� |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021030343-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135208-B2 |
| priorityDate | 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.